The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock.
about
Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)IAP antagonists induce anti-tumor immunity in multiple myeloma.Endoplasmic reticulum stress-induced degradation of DNAJB12 stimulates BOK accumulation and primes cancer cells for apoptosis.PI3K and Inhibitor of Apoptosis Proteins Modulate Gentamicin- Induced Hair Cell Death in the Zebrafish Lateral Line.Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery
P2860
The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The SMAC mimetic, LCL-161, red ...... eptibility to endotoxic shock.
@en
type
label
The SMAC mimetic, LCL-161, red ...... eptibility to endotoxic shock.
@en
prefLabel
The SMAC mimetic, LCL-161, red ...... eptibility to endotoxic shock.
@en
P2093
P2860
P50
P356
P1433
P1476
The SMAC mimetic, LCL-161, red ...... eptibility to endotoxic shock.
@en
P2093
A Banerjee
B P Martin
G Grigoriadis
P2860
P2888
P356
10.1038/ONCSIS.2016.26
P577
2016-04-04T00:00:00Z